https://americanpeptide.co/blogs/blog/fda-s-expanding-focus-from-ruo-platforms-to-mainstream-oversight 2026-01-28T07:02:31-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Rectangle_167_079aa7a9-e091-4183-860b-4d1bf8d30bed.png?v=1769601751 FDA’s Expanding Focus: From RUO Platforms to Mainstream Oversight https://americanpeptide.co/blogs/blog/kentucky-s-conflicting-signals-on-compounded-glp-1s 2026-01-28T07:03:07-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Rectangle_167_c5a5e1e4-e148-4741-9a46-41f2a1552815.png?v=1769601787 Kentucky’s Conflicting Signals on Compounded GLP-1s https://americanpeptide.co/blogs/blog/unique-issues-for-licensed-clinicians-prescribing-compounded-peptides 2026-01-28T07:02:56-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Rectangle_167_47fdb079-75a8-46a0-af61-9e2d7b0e3d56.png?v=1769601776 Unique Issues for Licensed Clinicians Prescribing Compounded Peptides https://americanpeptide.co/blogs/blog/beyond-fda-the-doj-s-expanding-role-in-health-product-enforcement 2026-01-28T07:02:44-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Rectangle_167.png?v=1769601764 Beyond FDA: The DOJ’s Expanding Role in Health Product Enforcement https://americanpeptide.co/blogs/blog/monitoring-europes-new-peptide-market-guidelines 2026-01-28T07:47:35-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/2d9a7dd3a759275b90d5eca132d4e5d840b10dc2.jpg?v=1769604455 Monitoring Europe's New Peptide Market Guidelines https://americanpeptide.co/blogs/blog/indiana-sb-282-2026-why-medical-spas-and-compounding-pharmacies-should-pay-attention-now 2026-01-28T07:08:18-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/woman-getting-treatment-hairdresser-shop-1-1.jpg?v=1769602098 Indiana SB 282 (2026): Why Medical Spas and Compounding Pharmacies Should Pay Attention Now https://americanpeptide.co/blogs/blog/in-case-you-missed-it-compounded-oral-semaglutide-went-from-launch-to-litigation-in-days 2026-02-11T11:27:29-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/close-up-portrait-brunette-fitness-woman-taking-dietary-supplements-vitamins-glass-water-1.webp?v=1770827249 In Case You Missed It: Compounded Oral Semaglutide Went From Launch to Litigation in Days https://americanpeptide.co/blogs/blog/florida-moves-to-license-medical-spas-what-hb-1429-means-for-the-medspa-and-wellness-industries 2026-03-19T15:48:47-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/beautician-makes-young-beautiful-girl-vacuum-facial-treatment-rejuvenation-girl-is-undergoing-course-spa-treatments-office-beautician-1-1.jpg?v=1773949727 Florida Moves to License Medical Spas: What HB 1429 Means for the Medspa and Wellness Industries https://americanpeptide.co/blogs/blog/from-scarlet-letter-to-a-supply-chain-near-you-some-category-2-peptides-are-getting-a-second-look 2026-03-03T12:30:44-05:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/imagebubbles.png?v=1772559044 From “Scarlet Letter” to a Supply Chain Near You: Some Category 2 Peptides Are Getting a Second Look https://americanpeptide.co/blogs/blog/how-to-successfully-launch-a-peptide-platform-balancing-innovation-with-regulatory-reality 2026-03-10T14:14:02-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/businessman-hands-tablet-digital-marketing-corporate-planning-strategy-web-design-office-hand-executive-testing-website-discussion-idea-ux-homepage-boardroom_1.jpg?v=1773166442 How to Successfully Launch a Peptide Platform: Balancing Innovation with Regulatory Reality https://americanpeptide.co/blogs/blog/novo-nordisk 2026-03-13T17:31:32-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/novo.jpg?v=1773437492 Rethinking the Narrative Around Compounding and Drug Safety https://americanpeptide.co/blogs/blog/aems-and-the-future-of-fda-postmarket-surveillance 2026-03-13T17:37:09-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/FDA_0988a07a-b78b-49b7-806e-845f53d1bf0a.jpg?v=1773437829 AEMS and the Future of FDA Postmarket Surveillance https://americanpeptide.co/blogs/blog/not-anti-regulation-just-better-regulation-florida-medspa-bill-hb-1429-dies-in-committee 2026-03-19T15:46:52-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/doctor-assistant-checking-medical-form.jpg?v=1773949612 Not Anti-Regulation, Just Better Regulation: Florida MedSpa Bill (HB 1429) Dies in Committee https://americanpeptide.co/blogs/blog/orforglipron-got-the-headlines-fda-s-fast-track-pilot-deserves-the-attention 2026-04-02T09:52:37-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/FDA_approves_new_pill_889bc57e-17f6-4f23-8a50-bdc0755ad870.jpg?v=1775137957 Orforglipron Got the Headlines. FDA’s Fast-Track Pilot Deserves the Attention. https://americanpeptide.co/blogs/blog/the-regulatory-middle-ground-navigating-non-pharmacy-supply-chains-in-clinical-practice 2026-05-15T12:08:02-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/pharmacist-scanning-medication-pharmacy.jpg?v=1778861282 The Regulatory Middle Ground: Navigating Non-Pharmacy Supply Chains in Clinical Practice https://americanpeptide.co/blogs/blog/peptide-industry-networking-how-to-build-your-professional-circle 2026-05-20T09:31:55-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Peptide_Industry_Networking_How_to_Build_Your_Professional_Circle_c60b95b8-a1a7-4dfa-bfd1-75e7beba0cc8.jpg?v=1779283915 Peptide Industry Networking — How to Build Your Professional Circle https://americanpeptide.co/blogs/blog/alabama-draws-a-line-on-research-grade-peptides-but-healthcare-providers-need-more-than-a-prohibition 2026-05-27T09:10:48-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/alabama_blog.jpg?v=1779887448 Alabama Draws a Line on Research-Grade Peptides — But Healthcare Providers Need More Than a Prohibition https://americanpeptide.co/blogs/blog/peptide-industry-membership-what-it-is-and-why-practitioners-join 2026-06-05T00:48:43-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Peptide_Industry_Membership_b9a03f8f-30c4-4db3-a9ae-42f664e1a099.jpg?v=1780634923 Peptide Industry Membership — What It Is and Why Practitioners Join https://americanpeptide.co/blogs/blog/the-blome-research-raid-facts-risks-and-industry-implications 2026-06-05T13:22:59-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/blome_6e749fcf-4b50-4a09-bce4-cafc88cc30d2.jpg?v=1780680179 The Blome Research Raid: Facts, Risks, and Industry Implications https://americanpeptide.co/blogs/blog/patients-deserve-to-know-what-they-are-getting 2026-06-19T17:52:08-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/55e6b0eb28e97d5fa935b34d90c7365b_exif.jpg?v=1781905928 Patients Deserve to Know What They Are Getting https://americanpeptide.co/blogs/blog/fda-s-bpc-157-review-leaves-the-real-world-record-out-of-frame 2026-07-30T03:00:48-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/image_14_4f74ff85-0ad3-495a-ba4e-b2fadc61c7bf.png?v=1785394848 FDA’s BPC-157 Review Leaves the Real-World Record Out of Frame https://americanpeptide.co/blogs/news/groundbreaking-clinical-research-from-apa-founding-member-vetbiologix 2026-07-24T06:51:51-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/groundbreaking-equine-peptide-research.png?v=1784890311 Groundbreaking Clinical Research from APA Founding Member VetBioLogix https://americanpeptide.co/blogs/news/forbes-highlights-the-payment-infrastructure-powering-the-peptide-industry 2026-07-24T06:50:19-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/payment-infrastructure-peptide-industry-forbes.png?v=1784890219 Forbes Highlights the Payment Infrastructure Powering the Peptide Industry https://americanpeptide.co/blogs/news/unapproved-retatrutide-sales-raise-safety-concerns-cbs-news 2026-07-24T06:46:27-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/unapproved-retatrutide-safety-concerns-cbs.png?v=1784889987 Unapproved Retatrutide Sales Raise Safety Concerns (CBS News) https://americanpeptide.co/blogs/news/brooklyn-bodega-highlights-consumer-demand-for-experimental-peptides-aol 2026-07-24T06:45:23-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/brooklyn-bodega-experimental-peptides-aol.png?v=1784889923 Brooklyn Bodega Highlights Consumer Demand for Experimental Peptides (AOL) https://americanpeptide.co/blogs/news/experimental-weight-loss-peptides-continue-to-drive-public-interest-yahoo-news 2026-07-24T06:44:25-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/experimental-weight-loss-peptides-yahoo-news.png?v=1784889865 Experimental Weight-Loss Peptides Continue to Drive Public Interest (Yahoo News) https://americanpeptide.co/blogs/news/consumer-interest-continues-to-shape-the-peptide-conversation-msn 2026-07-24T06:33:04-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/consumer-interest-peptide-conversation-msn.png?v=1784889184 Consumer Interest Continues to Shape the Peptide Conversation (MSN) https://americanpeptide.co/blogs/news/washington-post-examines-the-peptide-industrys-next-chapter 2026-07-24T06:31:41-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/washington-post-peptide-industry-next-chapter.png?v=1784889101 Washington Post Examines the Peptide Industry's Next Chapter https://americanpeptide.co/blogs/news/fda-discussions-continue-to-influence-the-peptide-market-investors-business-daily 2026-07-24T06:26:37-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/fda-discussions-peptide-market-ibd.png?v=1784888797 FDA Discussions Continue to Influence the Peptide Market (Investor's Business Daily) https://americanpeptide.co/blogs/news/fermentation-derived-peptides-gain-attention-beyond-healthcare 2026-07-24T06:25:07-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/fermentation-derived-peptides.png?v=1784888707 Fermentation-Derived Peptides Gain Attention Beyond Healthcare https://americanpeptide.co/blogs/news/healthcare-policy-continues-to-shape-innovation 2026-07-24T06:21:29-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/healthcare-policy-shapes-innovation.png?v=1784888489 Healthcare Policy Continues to Shape Innovation https://americanpeptide.co/blogs/news/fda-panel-reconsiders-peptide-policy-bloomberg-law 2026-07-24T06:16:46-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/fda-panel-reconsiders-peptide-policy-bloomberg-law.png?v=1784888206 FDA Panel Reconsiders Peptide Policy (Bloomberg Law) https://americanpeptide.co/blogs/news/reuters-covers-fda-peptide-review 2026-07-24T06:14:59-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/reuters-fda-peptide-review.png?v=1784888099 Reuters Covers FDA Peptide Review https://americanpeptide.co/blogs/blog/kpv-quality-controls-fda-limits-box-open 2026-07-30T03:34:10-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/KPV__Quality_Controls_FDA_s_Limits_and_What_Happens_Once_the_Box_Is_Open.jpg?v=1785396850 KPV: Quality Controls, FDA’s Limits, and What Happens Once the Box Is Open KPV: Quality Controls, FDA’s Limits, and What Happens Once the Box Is Open https://americanpeptide.co/blogs/blog/tb-500-human-evidence-different-molecule 2026-07-30T03:44:43-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/TB-500__When_the_Human_Evidence_Belongs_to_a_Different_Molecule_6d1af65f-d8b6-4cfa-9454-496822977281.webp?v=1785397483 TB-500: When the Human Evidence Belongs to a Different Molecule TB-500: When the Human Evidence Belongs to a Different Molecule https://americanpeptide.co/blogs/blog/mots-c-quality-floor-parallel-pathway 2026-07-30T03:51:21-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/MOTS-c__A_Quality_Floor_or_a_Parallel_Pathway.jpg?v=1785397881 MOTS-c: A Quality Floor—or a Parallel Pathway? MOTS-c: A Quality Floor—or a Parallel Pathway? https://americanpeptide.co/blogs/blog/day-two-pcac-peptide-molecule-identity-quality-guardrails 2026-07-30T04:01:36-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Day_Two_Opened_With_a_More_Fundamental_Question__Which_Molecule_Are_We_Talking_About_624fbf65-7fe3-4e6a-8237-2b018cc1ebcc.jpg?v=1785398496 Day Two Opened With a More Fundamental Question: Which Molecule Are We Talking About? https://americanpeptide.co/blogs/blog/emideltide-dsip-human-exposure-one-vote-divide 2026-07-30T04:54:24-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Emideltide_DSIP___Decades_of_Human_Exposure_and_a_One-Vote_Divide.jpg?v=1785401664 Emideltide (DSIP): Decades of Human Exposure and a One-Vote Divide https://americanpeptide.co/blogs/blog/epitalon-nomination-did-not-capture-full-record 2026-07-30T05:48:10-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Epitalon__When_the_Nomination_Did_Not_Capture_the_Full_Record_edc35e54-0d26-49a3-84f1-0ef13a1064da.jpg?v=1785404890 Epitalon: When the Nomination Did Not Capture the Full Record Epitalon: When the Nomination Did Not Capture the Full Record https://americanpeptide.co/blogs/blog/semax-foreign-clinical-use-fda-review-regulated-access 2026-07-30T05:30:17-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Semax__Foreign_Clinical_Use_Gaps_in_FDA_s_Review_and_a_Vote_for_Regulated_Access_c0a85352-49df-4e1c-ac3e-0db4a74eee24.jpg?v=1785403817 Semax: Foreign Clinical Use, Gaps in FDA’s Review, and a Vote for Regulated Access https://americanpeptide.co/blogs/blog/lilly-says-retatrutide-can-t-be-sold-it-s-also-fighting-fda-over-what-retatrutide-is 2026-08-14T14:39:35-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/fda-regulations.png?v=1786732775 Lilly Says Retatrutide Can’t Be Sold. It’s Also Fighting FDA Over What Retatrutide Is. https://americanpeptide.co/blogs/blog/peptide-industry-networking 2026-09-10T06:32:52-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Peptide_Industry_Networking__How_to_Build_Connections_That_Grow_Your_Practice_c0f5f2ba-4296-4cde-9861-3c8581e335a9.jpg?v=1789036372 Peptide Industry Networking: How to Build Connections That Grow Your Practice (2026) https://americanpeptide.co/blogs/blog/why-peptide-merchant-accounts-get-frozen 2026-09-18T07:57:00-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Why_Peptide_Merchant_Accounts_Get_Frozen.jpg?v=1789732620 Why Peptide Merchant Accounts Get Frozen - And What to Do in the First 48 Hours https://americanpeptide.co/blogs/blog/how-to-read-a-peptide-certificate-of-analysis 2026-09-24T09:02:18-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/How_to_Read_a_Peptide_Certificate_of_Analysis.png?v=1790254938 How to Read a Peptide Certificate of Analysis (Without Taking the Supplier's Word for It) https://americanpeptide.co/blogs/blog/pcac-vote-what-changed 2026-09-25T05:01:19-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/What_the_July_2026_PCAC_Vote_Actually_Changed_for_Your_Business.png?v=1790326879 What the July 2026 PCAC Vote Actually Changed for Your Business - And What It Didn't https://americanpeptide.co/blogs/blog/meta-google-ad-policy-for-peptide-clinics 2026-10-07T03:56:34-04:00 weekly https://cdn.shopify.com/s/files/1/0779/8256/4578/articles/Meta_Google_Ad_Policy_for_Peptide_Clinics.jpg?v=1791359794 Meta & Google Ad Policy for Peptide Clinics (2026)